Fundz

Jellatech reported raising $100,000 in an initial SEC Form D filing, from an offering of $100,000

PRIVATESep 07, 2023Late filing, first sale Oct 30, 2021

Amount Raised

$100,000

$100,000 sold, per SEC Form D (first sale Oct 30, 2021)

Round Type

Seed

RaleighBiotechnology

Quick answer

Jellatech raised $100,000 in a Seed round, dated October 30, 2021. Jellatech is based in Raleigh, North Carolina, United States.

How much did Jellatech raise?
Jellatech raised $100,000 in a Seed round on October 30, 2021.
What does Jellatech do?
Jellatech is a B2B biotech business based in Raleigh, NC.
Where is Jellatech based and how big is it?
Jellatech is based in Raleigh, North Carolina, United States.
Who are the decision-makers at Jellatech?
Fundz holds 1 contact at Jellatech. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Jellatech that raised within 45 days of this round, from Fundz verified event records.

  • Savran Technologies raised $4.2M (Seed) on December 14, 2021.
  • Lodestone Biomedical raised $450K (Seed) on December 14, 2021.
  • Cargene raised $19M (Funding Round) on December 14, 2021.
  • AnHeart Therapeutics raised $61M (Series B) on December 14, 2021.
  • Route 92 Medical raised $111M (Series E) on December 14, 2021.
  • Monod Bio, Inc. raised $6M on December 14, 2021.

Who to call at Jellatech, and when

A new round usually means Jellatech is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Jellatech raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Jellatech, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Jellatech. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Jellatech

Location

617 HUTTON STREET

Raleigh, North Carolina, United States

About

Jellatech is a B2B biotech business based in Raleigh, NC. Jellatech is producing high quality, pure, animal-free collagen and gelatin. Founded by a group of innovators, dreamers, entrepreneurs and scientists, Jellatech is eliminating the dependency on animals, to make better ingredient products - starting with collagen and gelatin. The collagen and gelatin industry is an industry that is based on the boiling of animal skin & bones and bits & pieces. Despite being on the back of animal carcasses and meat-industry byproducts, it’s a 3.5 billion dollar market with a 9% compound annual growth rate.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Jellatech raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Jellatech's next move

See what Strategic adds

Jellatech raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.